Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

AMACR anticorps

AMACR Reactivité: Humain IHC, StM Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN6939433
  • Antigène Voir toutes AMACR Anticorps
    AMACR (alpha-Methylacyl-CoA Racemase (AMACR))
    Reactivité
    • 100
    • 16
    • 12
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 64
    • 36
    • 2
    Lapin
    Clonalité
    • 53
    • 49
    Polyclonal
    Conjugué
    • 58
    • 8
    • 7
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp AMACR est non-conjugé
    Application
    • 69
    • 51
    • 39
    • 35
    • 18
    • 17
    • 13
    • 10
    • 7
    • 6
    • 6
    • 4
    • 3
    • 1
    • 1
    • 1
    • 1
    Immunohistochemistry (IHC), Staining Methods (StM)
    Specificité
    This antibody recognizes a protein of 54 kDa, which is identified as AMACR, also known as p504S. It is an enzyme that is involved in bile acid biosynthesis and -oxidation of branched-chain fatty acids. AMACR is essential in lipid metabolism. It is expressed in cells of premalignant high-grade prostatic intraepithelial neoplasia (HGPIN) and prostate adenocarcinoma. The majority of the carcinoma cells show a distinct granular cytoplasmic staining reaction. AMACR is present at low or undetectable levels in glandular epithelial cells of normal prostate and benign prostatic hyperplasia. A spotty granular cytoplasmic staining is seen in a few cells of the benign glands. AMACR is expressed in normal liver (hepatocytes), kidney (tubular epithelial cells) and gall bladder (epithelial cells). Expression has also been found in lung (bronchial epithelial cells) and colon (colonic surface epithelium). AMACR expression can also be found in hepatocellular carcinoma and kidney carcinoma. Past studies have also shown that AMACR is expressed in various colon carcinomas (well, moderately and poorly differentiated) and over expressed in prostate carcinoma.
    Immunogène
    A synthetic peptide from human AMACR protein
    Isotype
    IgG
    Top Product
    Discover our top product AMACR Anticorps primaire
  • Indications d'application

    Positive Control: HEK cells. Prostate Adenocarcinoma.

    Known Application: Immunohistochemistry (Formalin-fixed) (1:50-1:100 for 30-60 minutes at RT)(Staining of formalin-fixed tissues requires boiling tissue sections in 1 mM EDTA, pH 7.5-8.5, for 10-20 min followed by cooling at RT for 20 minutes)Optimal dilution for a specific application should be determined.

    Restrictions
    For Research Use only
  • Concentration
    200 μg/mL
    Buffer
    10 mM PBS with 0.05 % BSA & 0.05 % azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C,-80 °C
    Stockage commentaire
    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.
    Date de péremption
    24 months
  • Antigène
    AMACR (alpha-Methylacyl-CoA Racemase (AMACR))
    Autre désignation
    AMACR (AMACR Produits)
    Synonymes
    anticorps AMACR, anticorps DKFZp469O1232, anticorps amacr, anticorps NCU04099.1, anticorps MGC89832, anticorps AMACRD, anticorps CBAS4, anticorps RACE, anticorps RM, anticorps Macr1, anticorps Da1-8, anticorps Marc1, anticorps alpha-methylacyl-CoA racemase, anticorps PROBABLE ALPHA-METHYLACYL-COA RACEMASE MCR (2-methylacyl-CoA racemase) (2-arylpropionyl-CoA epimerase), anticorps Alpha-methylacyl-CoA racemase, anticorps alpha-methylacyl-CoA racemase L homeolog, anticorps AMACR, anticorps mcr, anticorps BPSL0064, anticorps Maqu_2037, anticorps UREG_03852, anticorps MCYG_01809, anticorps amacr, anticorps amacr.L, anticorps MGYG_04259, anticorps NCU04099, anticorps Amacr
    Poids moléculaire
    42kDa
    ID gène
    23600
    UniProt
    Q9UHK6
    Pathways
    Monocarboxylic Acid Catabolic Process
Vous êtes ici:
Support technique